LENZ THERAPEUTICS, INC. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (4 lists). Names and jurisdictions are as filed.
- 2026-03-24: Subsidiary LENZ Therapeutics Operations, Inc.; Jurisdiction Delaware.
- 2026-03-24: Subsidiary LENZ Netherlands B.V.; Jurisdiction Netherlands.
- 2024-02-27: Subsidiary None..
- 2023-03-20: Subsidiary None..
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-24 | LENZ Therapeutics Operations, Inc. | Delaware |
| 2026-03-24 | LENZ Netherlands B.V. | Netherlands |
| 2024-02-27 | None. | |
| 2023-03-20 | None. | |
| 2022-03-21 | None. |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |